Business Wire

PLANETS-CO-LTD

18.11.2022 18:01:38 CET | Business Wire | Press release

Share
teamLab Planets TOKYO: Tickets purchased from overseas have increased by 136% compared to the same month in 2019 (before the COVID-19 pandemic), with one in three visitors coming from overseas

teamLab Planets is a museum where visitors walk through water, and a garden where people become one with the flowers. The experiential museum has welcomed a cumulative total of over 3 million visitors since its opening in July 2018.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221117005639/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

teamLab, Floating Flower Garden; Flowers and I are of the Same Root, the Garden and I are One © teamLab

[Several new areas introduced during the pandemic]

Despite the impact of the coronavirus pandemic in 2020, various new areas have opened at the museum as featured on notable media such as CNN during the pandemic, including two large-scale artworks in the Garden Area, and an adjoining vegan ramen restaurant originating from Kyoto.

[Increase in foreign visitors due to the lifting of the ban on individual travel to Japan and the expansion of new areas]

On October 11, 2022, the Japanese government significantly eased the COVID-19 border measures. The ban on individual travel to Japan has been lifted, visa exemptions have returned and the daily limit on the number of people entering Japan has been removed. In response, tourism to Japan has resumed properly for the first time in about two and a half years.

Around a month since the lifting of the ban on individual travel to Japan on October 11, tickets purchased by visitors from overseas increased by 136% compared to the same month in 2019 (before COVID-19), with one in three visitors coming from overseas. (*1)
More than half of the visitors from overseas purchased their tickets before visiting Japan, and a trend has been seen in which the museum is one of the purposes for people to visit Tokyo. (*2)
In the visitor questionnaire, there have been positive comments from visitors from overseas, such as "I've been wanting to go to the museum since the renewal."

(*1) According to ticket purchase data from the teamLab Planets official website: survey period - October 11 (Tue) to November 6 (Sun), 2022, and October 11 (Fri) to November 6 (Wed) 2019
(*2) According to ticket purchase data from the teamLab Planets official website: survey period - October 11 (Tue) and November 6 (Sun), 2022

[High praise from travel magazines]

In recent years the museum has been featured in notable publications such as Lonely Planet, a world-famous travel guidebook, which introduced it as one of “The 7 best museums in Tokyo that even Tokyoites line up for”, as well as in “The 26 Best Things to Do in Tokyo” by Condé Nast Traveler.

We look forward to welcoming visitors that are sightseeing in Tokyo to experience the museum, which has evolved through new artwork spaces.

The museum will continue to provide people from around the world an experience based on the concept of teamLab Planets, “Immerse your Body, and with Others, Become One with the World”.

Garden Area

The Garden Area was unveiled in July 2021 featuring two large-scale artworks, including a garden with over 13,000 live orchids and a surreal art space with ovoids scattered across a floor covered in real moss. These new art spaces can only be experienced here, and explore people’s relationship with nature and the world through digital technology. By incorporating natural light in space, the works reveal different aspects during the day and after sunset.

Floating Flower Garden; Flowers and I are of the Same Root, the Garden and I are One
Artwork: https://planets.teamlab.art/tokyo/ew/ffgarden_planets/

Moss Garden of Resonating Microcosms - Solidified Light Color, Sunrise and Sunset
Artwork: https://planets.teamlab.art/tokyo/ew/resonating_microcosms_mossgarden_planets/

Food and Art: Enjoy vegan ramen in an art space

Vegan Ramen UZU Tokyo, a vegan ramen restaurant originating from Kyoto, opened in October 2021 on the same premises as teamLab Planets. Diners can enjoy ramen in teamLab’s Reversible Rotation - Non-Objective Space artwork space, as well as the Table of Sky and Fire and One Stroke Bench outside of the restaurant. Vegan Ramen UZU Tokyo also has vegan ice cream and various teas that are only available in Tokyo. The restaurant can be visited without entry to teamLab Planets.

Vegan Ramen UZU Tokyo: https://vegan-uzu.com/pages/uzu-tokyo

Public art that can be experienced by all

Universe of Fire Particles Falling from the Sky is a work of public art that depicts flames, on display since April 2021. Flames, which are a phenomenon of light and heat generated by combustion, are expressed as a collection of lines drawn in relation to the flow of combusting gas. The work is displayed outdoors and can be viewed by anyone, regardless of whether or not they enter the museum.

Universe of Fire Particles Falling from the Sky
Artwork: https://planets.teamlab.art/tokyo/ew/universe_fireparticles_falling/

[ teamLab Planets TOKYO DMM ]

teamLab Planets is a museum where you walk through water, and a garden where you become one with the flowers. There are four massive exhibition spaces and two gardens.

By immersing your entire body with other people in these massive artworks, the boundary between the body and the artwork dissolves. The self, others, and the world become continuous, and we explore a new relationship without boundaries between ourselves and the world.

Enter barefoot, immerse your body with others in the artwork spaces, and become one with the world.

[Exhibition details]

teamLab Planets TOKYO DMM
Location: teamLab Planets TOKYO, 6-1-16 Toyosu, Koto-ku, Tokyo

[Opening hours]

(November - January)
Mon - Fri 10:00 - 20:00
Saturdays, Sundays, and holidays 9:00 - 21:00
* December 26 (Mon) - December 30 (Fri), January 2 (Mon) - January 6 (Fri) 9:00 - 21:00
* December 31 (Sat), January 1 (Sun) 9:00 - 20:00
* Last entry is 1 hour before closing

Closed:
December 8 (Thu), January 11 (Wed)

*Opening hours are subject to change. Please check the official website for the latest updates.

Official website: https://planets.teamlab.art/tokyo/jp/
teamLab Planets Highlight Video: https://youtu.be/oiQoe9Ow9o0

*teamLab Planets will be open in Toyosu, Tokyo until the end of 2023.

[Tickets]

Adult: 3,200 yen
Junior high and high school students: 2,000 JPY
Children (4 to 12 years old): 1,000 JPY
3 years old and under: Free
Disability discount: 1,600 JPY

teamLab Planets TOKYO DMM Ticket Store: https://teamlabplanets.dmm.com

[Measures to prevent the spread of COVID-19s]

Please check the link below for details on the infection prevention measures implemented at teamLab Planets:
https://teamlabplanets.dmm.com/covid-19

[Official HP/Social Media]

Official website: https://planets.teamlab.art/tokyo/
Instagram: https://www.instagram.com/teamlab.planets/
Facebook: https://www.facebook.com/TL.Planets/
Twitter: https://twitter.com/teamLabPlanets
#teamLabPlanets

[Food & Shop]

Vegan Ramen UZU Tokyo: https://vegan-uzu.com/pages/uzu-tokyo
teamLab Flower Shop & Art
*Please check the official website for opening hours
*Closed on the same days as teamLab Planets

[New coronavirus measures (applicable to the Food & Shop)]

  • Implementation of regular cleaning and disinfection
  • Seat disinfection after each customer
  • Hand disinfection upon entry
  • Restrictions on the number of people in the space
  • Ensuring sufficient space between seats
  • Employees wear masks
  • Removal of tabletop items
  • Temperature measurement

[Press kit]

https://goo.gl/tQXMLm

[PLANETS Co., Ltd.]

Established in 2017. Operates and manages the facilities of teamLab Planets TOKYO.
Location: Tokyo Nihonbashi Tower 10F, 2-7-1 Nihonbashi, Chuo-ku, Tokyo
Representative: Takumi Nomoto

[teamLab]

teamLab (f. 2001) is an international art collective. Their collaborative practice seeks to navigate the confluence of art, science, technology, and the natural world. Through art, the interdisciplinary group of specialists, including artists, programmers, engineers, CG animators, mathematicians, and architects, aims to explore the relationship between the self and the world, and new forms of perception.

In order to understand the world around them, people separate it into independent entities with perceived boundaries between them. teamLab seeks to transcend these boundaries in our perceptions of the world, of the relationship between the self and the world, and of the continuity of time. Everything exists in a long, fragile yet miraculous, borderless continuity.

teamLab exhibitions have been held in cities worldwide, including New York, London, Paris, Singapore, Silicon Valley, Beijing, and Melbourne among others. teamLab museums and large-scale permanent exhibitions include teamLab Borderless and teamLab Planets in Tokyo, teamLab Borderless Shanghai, and teamLab SuperNature Macao, with more to open in cities including Abu Dhabi, Beijing, Hamburg, Jeddah, and Utrecht.

teamLab’s works are in the permanent collection of the Museum of Contemporary Art, Los Angeles; Art Gallery of New South Wales, Sydney; Art Gallery of South Australia, Adelaide; Asian Art Museum, San Francisco; Asia Society Museum, New York; Borusan Contemporary Art Collection, Istanbul; National Gallery of Victoria, Melbourne; and Amos Rex, Helsinki.

teamLab: https://www.teamlab.art/
Instagram: https://instagram.com/teamlab/
Facebook: https://www.facebook.com/teamLab.inc
Twitter: https://twitter.com/teamLab_net
YouTube: https://www.youtube.com/c/teamLabART

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221117005639/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release

- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release

New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release

Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea

Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press release

Phase Ia BreAK CRC-001 at ESMO 2026: 43% of patients, all initially unresectable, became eligible for surgery Poster 1023P – Developmental Therapeutics Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by u

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye